116 related articles for article (PubMed ID: 16077084)
1. Focus issue: drug discovery.
Gough NR
Sci STKE; 2005 Aug; 2005(295):eg7. PubMed ID: 16077084
[TBL] [Abstract][Full Text] [Related]
2. Focus issue: RNA, a multifunctional molecule.
Gough NR; Adler EM
Sci STKE; 2005 Sep; 2005(300):eg8. PubMed ID: 16145016
[TBL] [Abstract][Full Text] [Related]
3. Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens.
Perrimon N; Friedman A; Mathey-Prevot B; Eggert US
Drug Discov Today; 2007 Jan; 12(1-2):28-33. PubMed ID: 17198970
[TBL] [Abstract][Full Text] [Related]
4. How will RNAi facilitate drug development?
Bartz S; Jackson AL
Sci STKE; 2005 Aug; 2005(295):pe39. PubMed ID: 16077085
[TBL] [Abstract][Full Text] [Related]
5. Focus issue: signaling across membranes.
Gough NR
Sci STKE; 2005 Dec; 2005(313):eg11. PubMed ID: 16333016
[TBL] [Abstract][Full Text] [Related]
6. Focus issue: measurement on a small scale.
Gough NR
Sci STKE; 2006 Mar; 2006(327):eg4. PubMed ID: 16552089
[TBL] [Abstract][Full Text] [Related]
7. Focus issue: memories of signals past--plastic changes in nervous system function.
Adler EM; Gough NR
Sci STKE; 2005 Nov; 2005(309):eg10. PubMed ID: 16278486
[TBL] [Abstract][Full Text] [Related]
8. Commercial potential of RNAi.
Jain KK
Mol Biosyst; 2006 Nov; 2(11):523-6. PubMed ID: 17216033
[TBL] [Abstract][Full Text] [Related]
9. RNA interference strategies as therapy for respiratory viral infections.
DeVincenzo JP
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S118-22. PubMed ID: 18820571
[TBL] [Abstract][Full Text] [Related]
10. Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapy.
Kieburtz K; Olanow CW
Mt Sinai J Med; 2007 Apr; 74(1):7-14. PubMed ID: 17516559
[TBL] [Abstract][Full Text] [Related]
11. Proteomic methods for drug target discovery.
Sleno L; Emili A
Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
[TBL] [Abstract][Full Text] [Related]
12. Focus issue: going for the gut.
Adler EM
Sci STKE; 2005 Mar; 2005(277):eg4. PubMed ID: 15798099
[TBL] [Abstract][Full Text] [Related]
13. The target discovery process.
Egner U; Krätzschmar J; Kreft B; Pohlenz HD; Schneider M
Chembiochem; 2005 Mar; 6(3):468-79. PubMed ID: 15742383
[TBL] [Abstract][Full Text] [Related]
14. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide application of RNAi to the discovery of potential drug targets.
Ito M; Kawano K; Miyagishi M; Taira K
FEBS Lett; 2005 Oct; 579(26):5988-95. PubMed ID: 16153642
[TBL] [Abstract][Full Text] [Related]
16. Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo.
Powell DR
Obes Rev; 2006 Feb; 7(1):89-108. PubMed ID: 16436105
[TBL] [Abstract][Full Text] [Related]
17. Exploring the sounds of silence: RNAi-mediated gene silencing for target identification and validation.
Chatterjee-Kishore M; Miller CP
Drug Discov Today; 2005 Nov; 10(22):1559-65. PubMed ID: 16257379
[TBL] [Abstract][Full Text] [Related]
18. Challenges of drug discovery for personalized medicine.
Jain KK
Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
[TBL] [Abstract][Full Text] [Related]
19. RNA interference screening for the discovery of oncology targets.
Quon K; Kassner PD
Expert Opin Ther Targets; 2009 Sep; 13(9):1027-35. PubMed ID: 19650760
[TBL] [Abstract][Full Text] [Related]
20. The 7 TM G-protein-coupled receptor target family.
Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
